GHSI - Guardion Health Net Sales Margin

Guardion Health - graphic logo of issuer GHSI

The credit profile stability of Guardion Health Science (GHSI) is based on proprietary formulas and in-house capacities in the US. The net margin per unit of revenue demonstrates pricing power, with the indicator value standing at -62.90. The financial reserve is supported by the efficiency of DTC channels for nutraceutical sales, as well as capital allocation following the divestiture of core operational nutrition brands from the business.

Guardion Health Science (GHSI) - Company Sales Margin from 07/04/2022 to 10/19/2024

Comprehensive metric breakdowns and analytics for Guardion Health Science (GHSI)

- market value and analyst target forecast:
Summary company analytics:Guardion Health Sciences - GHSI
Manufactured product of Guardion Health

Guardion Health Science occupies a high-tech niche within the ophthalmological nutraceuticals sector. By analyzing the company's net profit margin, an investor can see the proportion of actual profit relative to total revenue. This metric is calculated as the ratio of net income to sales, reflecting overall operational efficiency. The automation of production lines using AI manipulators should systematically reduce costs, thereby increasing this figure. Expanding margins confirm the fundamental stability of the business and the scalability of its robotic model.